Across TCGA pan-cancer cohorts, CYTOR RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated CYTOR data layer compared with 1 for mutation status.
The strongest signal is observed in uveal melanoma (UVM), where higher CYTOR RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CYTOR expression acts as an unfavorable survival marker, although some lineages such as SKCM and ESCA show a favorable association.
UVM, ACC, and KIRC are the cancer types where CYTOR RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.